Fineline Cube

Follow:
14398 Articles
RemeGen's Taixia Pu Gets CDE Nod for Potential New Indication in Advanced Gastric Cancer
CompanyDrug

RemeGen’s Taitaxipu Receives CDE Acceptance for New Indication Application in China

CompanyMedical Device

Shanghai MicroPort Initiates Pre-Marketing Clinical Study for Embolic Microspheres in Liver Cancer Treatment

Chongqing Zhifei Biological's Influenza Vaccine Application Accepted by China's Drug Evaluation Center
CompanyDrug

Chongqing Zhifei Biological’s Influenza Vaccine Application Accepted by China’s Drug Evaluation Center

TheDerma's Series A+ Round to Fund R&D and Commercialization of AhR Targeted Drugs
Company

TheDerma’s Series A+ Round to Fund R&D and Commercialization of AhR Targeted Drugs

Jiangxi Province to Implement Direct Medical Insurance Fund Payments for NRDL Drugs from December 2024
Policy / Regulatory

Jiangxi Province to Implement Direct Medical Insurance Fund Payments for NRDL Drugs from December 2024

BMS Launches Cardiac Myosin Inhibitor Camzyos in China for Obstructive Hypertrophic Cardiomyopathy
CompanyDrug

BMS Launches Cardiac Myosin Inhibitor Camzyos in China for Obstructive Hypertrophic Cardiomyopathy

Boston Scientific Reports 19.5% YOY Increase in Q3 Net Sales, Driven by New Product Launches and Market Expansion
Company

Boston Scientific Reports 19.5% YOY Increase in Q3 Net Sales, Driven by New Product Launches and Market Expansion

Hengrui Medicine Considers HKEX Secondary Listing Amid Financing Challenges in Mainland China
Company

Hengrui Pharmaceuticals Considers HKEX Secondary Listing Amid Financing Challenges in Mainland China

Everest Medicines’ Velsipity Approved for Use in Select Hospitals in China’s Greater Bay Area
CompanyDrug

Everest Medicines’ Velsipity Approved for Use in Select Hospitals in China’s Greater Bay Area

Daiichi Sankyo’s Pexidartinib Poised for Priority Review in China for TGCT Treatment
CompanyDrug

Daiichi Sankyo’s Pexidartinib Poised for Priority Review in China for TGCT Treatment

AbbVie and Gedeon Richter Expand Partnership to Develop Novel Neuropsychiatric Targets
CompanyDeals

AbbVie and Gedeon Richter Expand Partnership to Develop Novel Neuropsychiatric Targets

Asieris Pharmaceuticals Gets FDA Green Light for USP1 Inhibitor APL-2302 in Advanced Solid Tumors
CompanyDrug

Asieris Pharmaceuticals Gets FDA Green Light for USP1 Inhibitor APL-2302 in Advanced Solid Tumors